Cardiology, Cardiovascular Center, University Hospital Zurich, Raemistrasse 100, Zurich, Switzerland.
Eur Heart J. 2011 May;32(9):1077-88. doi: 10.1093/eurheartj/ehr076. Epub 2011 Mar 7.
Short QT syndrome (SQTS) is a genetically determined ion-channel disorder, which may cause malignant tachyarrhythmias and sudden cardiac death. Thus far, mutations in five different genes encoding potassium and calcium channel subunits have been reported. We present, for the first time, a novel loss-of-function mutation coding for an L-type calcium channel subunit.
The electrocardiogram of the affected member of a single family revealed a QT interval of 317 ms (QTc 329 ms) with tall, narrow, and symmetrical T-waves. Invasive electrophysiological testing showed short ventricular refractory periods and increased vulnerability to induce ventricular fibrillation. DNA screening of the patient identified no mutation in previously known SQTS genes; however, a new variant at a heterozygous state was identified in the CACNA2D1 gene (nucleotide c.2264G > C; amino acid p.Ser755Thr), coding for the Ca(v)α(2)δ-1 subunit of the L-type calcium channel. The pathogenic role of the p.Ser755Thr variant of the CACNA2D1 gene was analysed by using co-expression of the two other L-type calcium channel subunits, Ca(v)1.2α1 and Ca(v)β(2b), in HEK-293 cells. Barium currents (I(Ba)) were recorded in these cells under voltage-clamp conditions using the whole-cell configuration. Co-expression of the p.Ser755Thr Ca(v)α(2)δ-1 subunit strongly reduced the I(Ba) by more than 70% when compared with the co-expression of the wild-type (WT) variant. Protein expression of the three subunits was verified by performing western blots of total lysates and cell membrane fractions of HEK-293 cells. The p.Ser755Thr variant of the Ca(v)α(2)δ-1 subunit was expressed at a similar level compared with the WT subunit in both fractions. Since the mutant Ca(v)α(2)δ-1 subunit did not modify the expression of the pore-forming subunit of the L-type calcium channel, Ca(v)1.2α1, it suggests that single channel biophysical properties of the L-type channel are altered by this variant.
In the present study, we report the first pathogenic mutation in the CACNA2D1 gene in humans, which causes a new variant of SQTS. It remains to be determined whether mutations in this gene lead to other manifestations of the J-wave syndrome.
短 QT 综合征(SQTS)是一种遗传性离子通道疾病,可能导致恶性室性心律失常和心源性猝死。迄今为止,已经报道了五个不同基因编码钾和钙通道亚基的突变。我们首次报道了一种新型的 L 型钙通道亚基失活突变。
一个单家族受影响成员的心电图显示 QT 间期为 317ms(QTc 329ms),伴有高大、狭窄和对称的 T 波。侵入性电生理测试显示心室不应期缩短,易诱发心室颤动。对患者的 DNA 筛查未发现先前已知的 SQTS 基因的突变;然而,在 CACNA2D1 基因(核苷酸 c.2264G>C;氨基酸 p.Ser755Thr)中发现了一个杂合状态的新变异,该基因编码 L 型钙通道的 Ca(v)α(2)δ-1 亚基。通过在 HEK-293 细胞中共表达另外两个 L 型钙通道亚基 Ca(v)1.2α1 和 Ca(v)β(2b),分析了 CACNA2D1 基因 p.Ser755Thr 变异的致病作用。在这些细胞中,使用全细胞膜片钳记录电压钳条件下的钡电流(I(Ba))。与共表达野生型(WT)变体相比,共表达 p.Ser755Thr Ca(v)α(2)δ-1 亚基可使 I(Ba)降低 70%以上。通过对 HEK-293 细胞总裂解物和细胞膜部分的 Western blot 验证了三个亚基的蛋白表达。在这两个部分,p.Ser755Thr Ca(v)α(2)δ-1 亚基的表达水平与 WT 亚基相似。由于突变的 Ca(v)α(2)δ-1 亚基不改变 L 型钙通道的孔形成亚基 Ca(v)1.2α1 的表达,这表明该变体改变了 L 型通道的单个通道生物物理特性。
在本研究中,我们首次报道了 CACNA2D1 基因在人类中的致病性突变,该突变导致了一种新的 SQTS 变异。尚不确定该基因的突变是否会导致 J 波综合征的其他表现。